Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape

Acceleron Pharma, Inc. (NASDAQ: XLRN) was a big mover last session, as its shares rose over 13% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since March 3, as the stock is now down nearly 27%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Acceleron Pharma currently has a Zacks Rank #3 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Alkermes plc (NASDAQ: ALKS) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 
ALKERMES INC (NASDAQ: ALKS): Free Stock Analysis Report
 
ALEXION PHARMA (NASDAQ: ALXN): Free Stock Analysis Report
 
ANI PHARMACEUT (NASDAQ: ANIP): Free Stock Analysis Report
 
ACCELERON PHARM (NASDAQ: XLRN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research